TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CELU

Celularity Inc

Healthcare · Biotechnology

1.30$ +3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Celularity Inc (CELU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 107 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CELU
Line item Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
246 157 157 144 144 129 133 133 120 114 107 107
18 16 16 23 20 15 21 21 17 11 12 12
3.1 0.3 0.3 1.9 0.2 0.1 0.7 0.7 0.9 0.1 6.2 6.2
3.1 0.3 0.2 0.1 0.7 0.9 0.1 6.2
4.9 4.1 6.2 14 12 8.8 14 14 11 6.7 4.7 4.7
5.7 4.9 4.9 3.7 5.8 4.0 5.4 5.4 4.4 2.6 0.6 0.6
86
90 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3 7.3
12 12 12 10 11 9.6 9.2 9.2 8.5 8.1 7.8 7.8
128 127 127 113 103 112 124 124 146 134 145 145
65 85 85 66 67 76 54 54 69 65 81 81
17 35 39 43 6.4 6.9 5.7 14
12 13 13 13 14 15 23 23 24 25 26 26
17 36 36 36
119 30 30 31 41 17 8.8 8.8 -25 -20 -38 -38
-757 -851 -851 -864 -842 -886 -900 -900 -944 -967 -991 -991
18 19 19 22 19 22 23 22 24 26 29 26

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?